AU4120096A - Production of recombinant peptides as natural hydrophobic peptide analogues - Google Patents

Production of recombinant peptides as natural hydrophobic peptide analogues

Info

Publication number
AU4120096A
AU4120096A AU41200/96A AU4120096A AU4120096A AU 4120096 A AU4120096 A AU 4120096A AU 41200/96 A AU41200/96 A AU 41200/96A AU 4120096 A AU4120096 A AU 4120096A AU 4120096 A AU4120096 A AU 4120096A
Authority
AU
Australia
Prior art keywords
production
peptide analogues
recombinant peptides
hydrophobic peptide
natural hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU41200/96A
Other versions
AU704594B2 (en
Inventor
Hans Binz
Thien Nguyen Ngoc
Per Ake Nygren
Stefan Stahl
Mathias Uhlen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU4120096A publication Critical patent/AU4120096A/en
Application granted granted Critical
Publication of AU704594B2 publication Critical patent/AU704594B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU41200/96A 1994-11-07 1995-11-07 Production of recombinant peptides as natural hydrophobic peptide analogues Ceased AU704594B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9413307A FR2726576B1 (en) 1994-11-07 1994-11-07 PRODUCTION OF HYDROPHOBIC PEPTIDE-LIKE PEPTIDES, RECOMBINANT PEPTIDE, CORRESPONDING DNA SEQUENCE
FR94/13307 1994-11-07
PCT/FR1995/001464 WO1996014409A1 (en) 1994-11-07 1995-11-07 Production of recombinant peptides as natural hydrophobic peptide analogues

Publications (2)

Publication Number Publication Date
AU4120096A true AU4120096A (en) 1996-05-31
AU704594B2 AU704594B2 (en) 1999-04-29

Family

ID=9468565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41200/96A Ceased AU704594B2 (en) 1994-11-07 1995-11-07 Production of recombinant peptides as natural hydrophobic peptide analogues

Country Status (8)

Country Link
EP (1) EP0791059A1 (en)
JP (1) JPH10508479A (en)
AU (1) AU704594B2 (en)
CA (1) CA2204511A1 (en)
FR (1) FR2726576B1 (en)
NZ (1) NZ296562A (en)
WO (1) WO1996014409A1 (en)
ZA (1) ZA959417B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046581A1 (en) * 1996-06-05 1997-12-11 Biomolecular Research Institute Ltd. Viral peptides with structural homology to protein g of respiratory syncytial virus

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789653A (en) * 1995-01-10 1998-08-04 University Of Edinburgh Secretory gene trap
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
FR2766192B1 (en) * 1997-07-17 2001-07-13 Pf Medicament EPITOPES OF RSV AND ANTIBODIES COMPRISING SAME, USEFUL IN DIAGNOSIS AND THERAPY
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
FR2819810B1 (en) * 2001-01-23 2004-05-28 Pf Medicament NON-GLYCOSYL PEPTIDES DERIVED FROM RSV PROTEIN G AND THEIR USE IN A VACCINE
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
ES2500918T3 (en) 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Albumin and interferon beta fusion proteins
JP6744225B2 (en) * 2014-02-14 2020-08-19 シンヴィヴォ コーポレイション Hybrid proteins and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605476B2 (en) * 1986-01-14 1991-01-17 University Of North Carolina, The Vaccines for human respiratory virus
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
AU7410987A (en) * 1986-06-12 1988-01-07 Immunex Corp. Polypeptides devoid of hydrophobic amino acids
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
EP0452364B1 (en) * 1988-12-22 2002-05-22 Genentech, Inc. Method for preparing water soluble polypeptides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046581A1 (en) * 1996-06-05 1997-12-11 Biomolecular Research Institute Ltd. Viral peptides with structural homology to protein g of respiratory syncytial virus

Also Published As

Publication number Publication date
FR2726576A1 (en) 1996-05-10
JPH10508479A (en) 1998-08-25
EP0791059A1 (en) 1997-08-27
FR2726576B1 (en) 1997-01-31
AU704594B2 (en) 1999-04-29
WO1996014409A1 (en) 1996-05-17
NZ296562A (en) 1999-11-29
ZA959417B (en) 1996-06-11
CA2204511A1 (en) 1996-05-17

Similar Documents

Publication Publication Date Title
AU6360394A (en) Vasonatrin peptide and analogs thereof
IL121520A (en) Polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive or a fragment or truncation thereof
PL320824A1 (en) Aerodol form of a preparation of peptides and proteins
HUP0000810A3 (en) Proteins with enhanced levels of essential amino acids
AU4727296A (en) Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
AU6486196A (en) Novel factor viii:c polypeptide analogs with altered protease sites
AU4415796A (en) Production of c-terminal amidated peptides from recombinant protein constructs
AU5360796A (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
AU1159897A (en) Analogs of peptide yy and uses thereof
AU3236297A (en) Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
AU4120096A (en) Production of recombinant peptides as natural hydrophobic peptide analogues
AU2091799A (en) Uses of alpha-conotoxin peptides
AU5635896A (en) Recombinant endotoxin-neutralizing proteins
AU8059391A (en) Method of making peptides
AU1884297A (en) Recombinant protein containing a c-terminal fragment of plasmodium msp-1
IL116973A0 (en) Extraction of recombinant proteins
GB9714680D0 (en) Recombinant production of proteins
AU2241699A (en) Expression of proteolytically-sensitive peptides
AU2004595A (en) Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural N-terminal sequence
AU4282599A (en) Method to prepare c-terminal modified peptides
GB9104596D0 (en) Production of recombinant proteins
AU3817497A (en) Production of recombinant plasma gelsolin containing a disulfide bond
GB9714681D0 (en) Recombinant production of proteins
AU1454495A (en) Recombinant production of modified proteins lacking certain amino acids
AU7085398A (en) Process for esterification of amino acids and peptides

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired